Loading…
Reported covered position: Rep. Rogers, Chief of Staff, LD, LA
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PARTNER THERAPUTICS via EAST END GROUP, LLC
2026 · third_quarter · 3A
Legislative and regulatory issues pertaining to the development and procurement of medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PARTNER THERAPUTICS via EAST END GROUP, LLC
2026 · third_quarter · Q3
Source: Senate LDA
| ALVOGEN |
| 34 |
| 2018–2025 |
| AMGEN, INC. | 29 | 2014–2020 |
| PFENEX INC | 20 | 2014–2019 |
| AMAZON | 19 | 2020–2023 |
| ASTRAZENECA | 18 | 2014–2018 |
| ALERE INC. | 15 | 2014–2017 |
| SMITH & NEPHEW | 15 | 2014–2017 |
| FRESENIUS MEDICAL CARE NORTH AMERICA | 14 | 2021–2023 |
| LONGHORN | 14 | 2023–2026 |
| RAI SERVICES COMPANY | 13 | 2020–2022 |
| Corbus Pharmaceuticals Holdings, Inc. | 11 | 2018–2020 |
| DAIICHI SANKYO INC | 10 | 2017–2019 |
| RIDGEBACK BIOTHERAPEUTICS | 10 | 2020–2022 |
| MESO SCALE DIAGNOSTICS | 9 | 2020–2022 |
| ALKERMES | 8 | 2014–2015 |
| EXELIXIS, INC. | 8 | 2018–2019 |
| ORGANOVO | 8 | 2016–2017 |
| PARTNER THERAPUTICS | 8 | 2025–2026 |
| PAXVAX | 7 | 2017–2018 |
| Fresenius Kabi | 5 | 2025–2026 |
| ILLUMNIA, INC. | 5 | 2023 |
| INVIVYD, INC. | 5 | 2024 |
| EAST END GROUP, LLC | 1 | 2010 |
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; reforms to H.R. 3590, the Patient Protection and Affordable Care Act; regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PAXVAX · Firm: EAST END GROUP, LLC
H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Health and Human Services Appropriations, FDA regulatory issues and issues related to Priority Review Voucher programs.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PAXVAX · Firm: EAST END GROUP, LLC
H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Health and Human Services Appropriations, FDA regulatory issues and issues related to Priority Review Voucher programs.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; and the Food and Drug Administration legislative and regulatory issues.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
Prescription Drug User Fee Act Re-authorization; HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
Prescription Drug User Fee Act Re-authorization, H.R. 2025, the Abuse-Deterrent Opioids Plan for Tomorrow Act.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; issues related to the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
Issues relate to appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act related to diagnostics; issues related to diagnostics in the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; reforms to H.R. 3590, the Patient Protection and Affordable Care Act; regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
Issues relate to appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act related to diagnostics; issues related to diagnostics in the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; issues related to the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; issues related to the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; issues related to the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Medical Countermeasure Innovation Act of 2016
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues.
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act; regulatory issues related to biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act; regulatory issues related to biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Medical Countermeasure Innovation Act of 2016
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Medical Countermeasure Innovation Act of 2016
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to biodefense vaccine development and procurement; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Medical Countermeasure Innovation Act of 2016
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Medical Countermeasure Innovation Act of 2016
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to biodefense vaccine development and procurement; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Issues related to pandemic influenza funding, federal oversight of pandemic manufacturing facilities and passage of S 2055, the Medical Countermeasure Innovation Act.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Legislative and regulatory issues pertaining to the development and procurement of medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2026 · third_quarter · Q3
Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS KABI via EAST END GROUP, LLC
2026 · second_quarter · Q2
Funding and incentives for domestic manufacturing. Regulatory and legislative issues related to on-shoring and procurement of sterile injectable products and related medical devices.
Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PARTNER THERAPUTICS via EAST END GROUP, LLC
2026 · second_quarter · Q2
Legislative and regulatory issues pertaining to the development and procurement of medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
LONGHORN via EAST END GROUP, LLC
2026 · second_quarter · Q2
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2026 · second_quarter · Q2
Legislatives issues related to pandemic preparedness and response. Drug pricing reform. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2026 · second_quarter · Q2
Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS KABI via EAST END GROUP, LLC
2026 · first_quarter · Q1
Funding and incentives for domestic manufacturing. Regulatory and legislative issues related to on-shoring and procurement of sterile injectable products and related medical devices.
Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PARTNER THERAPUTICS via EAST END GROUP, LLC
2026 · first_quarter · Q1
Legislative and regulatory issues pertaining to the development and procurement of medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
LONGHORN via EAST END GROUP, LLC
2026 · first_quarter · Q1
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2026 · first_quarter · Q1
Legislatives issues related to pandemic preparedness and response. Drug pricing reform. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2026 · first_quarter · 1A
Phrma - General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2026 · first_quarter · Q1
Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2026 · first_quarter · Q1
Phrma - General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS KABI via EAST END GROUP, LLC
2025 · fourth_quarter · Q4
Funding and incentives for domestic manufacturing. Regulatory and legislative issues related to on-shoring and procurement of sterile injectable products and related medical devices.
Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PARTNER THERAPUTICS via EAST END GROUP, LLC
2025 · fourth_quarter · Q4
Legislative and regulatory issues pertaining to the development and procurement of medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
LONGHORN via EAST END GROUP, LLC
2025 · fourth_quarter · Q4
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2025 · fourth_quarter · Q4
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals. Issues related to domestic manufacturing and on-shoring pharmaceuticals.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SEQIRUS via EAST END GROUP, LLC
2025 · fourth_quarter · Q4
Legislatives issues related to pandemic preparedness and response. Drug pricing reform. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2025 · fourth_quarter · Q4
Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2025 · fourth_quarter · Q4
Phrma - General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS KABI via EAST END GROUP, LLC
2025 · third_quarter · Q3
Funding and incentives for domestic manufacturing. Regulatory and legislative issues related to on-shoring and procurement of sterile injectable products and related medical devices.
Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
FRESENIUS KABI via EAST END GROUP, LLC
2025 · third_quarter · RR
Buy America legislation, tariffs, regulatory incentives for domestic manufacturing, and Section 232 investigation into pharmaceuticals and unfair trade practices.
Buy America legislation, tariffs, regulatory incentives for domestic manufacturing, and Section 232 investigation into pharmaceuticals and unfair trade practices.
Buy America legislation, tariffs, regulatory incentives for domestic manufacturing, and Section 232 investigation into pharmaceuticals and unfair trade practices.
PARTNER THERAPUTICS via EAST END GROUP, LLC
2025 · third_quarter · Q3
Legislative and regulatory issues pertaining to the development and procurement of medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
LONGHORN via EAST END GROUP, LLC
2025 · third_quarter · Q3
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2025 · third_quarter · Q3
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
SEQIRUS via EAST END GROUP, LLC
2025 · third_quarter · Q3
Legislatives issues related to pandemic preparedness and response. Drug pricing reform. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2025 · third_quarter · Q3
Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2025 · third_quarter · Q3
Phrma - General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNER THERAPUTICS via EAST END GROUP, LLC
2025 · second_quarter · Q2
Legislative and regulatory issues pertaining to the development and procurement of medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNER THERAPUTICS via EAST END GROUP, LLC
2025 · second_quarter · RR
Issues pertaining to the development of emergency medical countermeasures.
LONGHORN via EAST END GROUP, LLC
2025 · second_quarter · Q2
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2025 · second_quarter · Q2
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2025 · second_quarter · Q2
Legislatives issues related to pandemic preparedness and response. Drug pricing reform. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2025 · second_quarter · Q2
Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2025 · second_quarter · Q2
Phrma - General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2025 · second_quarter · 2T
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2025 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGHORN via EAST END GROUP, LLC
2025 · first_quarter · Q1
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2025 · first_quarter · Q1
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2025 · first_quarter · Q1
Legislatives issues related to pandemic preparedness and response. Drug pricing reform. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2025 · first_quarter · Q1
Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2025 · first_quarter · Q1
Phrma - General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2025 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGHORN via EAST END GROUP, LLC
2024 · fourth_quarter · Q4
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2024 · fourth_quarter · Q4
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2024 · fourth_quarter · Q4
Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2024 · fourth_quarter · Q4
Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2024 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform and related issues; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2024 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVIVYD, INC. via EAST END GROUP, LLC
2024 · third_quarter · 3T
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVIVYD, INC. via EAST END GROUP, LLC
2024 · third_quarter · Q3
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGHORN via EAST END GROUP, LLC
2024 · third_quarter · Q3
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2024 · third_quarter · Q3
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2024 · third_quarter · Q3
Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2024 · third_quarter · Q3
Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2024 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform and related issues; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2024 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVIVYD, INC. via EAST END GROUP, LLC
2024 · second_quarter · Q2
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGHORN via EAST END GROUP, LLC
2024 · second_quarter · Q2
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2024 · second_quarter · Q2
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2024 · second_quarter · Q2
Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2024 · second_quarter · Q2
Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2024 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform and related issues; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2024 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVIVYD, INC. via EAST END GROUP, LLC
2024 · first_quarter · Q1
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVIVYD, INC. via EAST END GROUP, LLC
2024 · first_quarter · RR
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.
LONGHORN via EAST END GROUP, LLC
2024 · first_quarter · Q1
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2024 · first_quarter · Q1
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2024 · first_quarter · Q1
Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2024 · first_quarter · Q1
Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2024 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform and related issues; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2024 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGHORN via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ILLUMNIA, INC. via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
Legislative and regulatory issues related to biodefense preparedness and response, diagnostics testing and surveillance, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
Legislative and regulatory issues related to dialysis and kidney care services, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Federal funding for preparedness efforts related to dialysis and kidney care services in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
Legislative and regulatory issues related to COVID-19 preparedness, general health care coverage and reimbursement, telemedicine, and the Food and Drug Administration.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform and related issues; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2023 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGHORN via EAST END GROUP, LLC
2023 · third_quarter · Q3
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ILLUMNIA, INC. via EAST END GROUP, LLC
2023 · third_quarter · Q3
Legislative and regulatory issues related to biodefense preparedness and response, diagnostics testing and surveillance, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2023 · third_quarter · Q3
Legislative and regulatory issues related to dialysis and kidney care services, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Federal funding for preparedness efforts related to dialysis and kidney care services in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2023 · third_quarter · Q3
Legislative and regulatory issues related to COVID-19 preparedness, general health care coverage and reimbursement, telemedicine, and the Food and Drug Administration.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2023 · third_quarter · Q3
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2023 · third_quarter · Q3
Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2023 · third_quarter · Q3
Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2023 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2023 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform and related issues; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGHORN via EAST END GROUP, LLC
2023 · second_quarter · Q2
Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGHORN via EAST END GROUP, LLC
2023 · second_quarter · RR
Legislative and regulatory issues related vaccine and diagnostic research, development and stockpiling. The reauthorization of the Pandemic and All-Hazards Preparedness Act. Federal funding for related issues in the LHHS Appropriations bill.
ILLUMNIA, INC. via EAST END GROUP, LLC
2023 · second_quarter · Q2
Legislative and regulatory issues related to biodefense preparedness and response, diagnostics testing and surveillance, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2023 · second_quarter · Q2
Legislative and regulatory issues related to dialysis and kidney care services, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Federal funding for preparedness efforts related to dialysis and kidney care services in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2023 · second_quarter · Q2
Legislative and regulatory issues related to COVID-19 preparedness, general health care coverage and reimbursement, telemedicine, and the Food and Drug Administration.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2023 · second_quarter · Q2
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2023 · second_quarter · Q2
Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2023 · second_quarter · Q2
Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE